183 related articles for article (PubMed ID: 14627991)
1. Serine mutations that abrogate ligand-induced ubiquitination and internalization of the EGF receptor do not affect c-Cbl association with the receptor.
Oksvold MP; Thien CB; Widerberg J; Chantry A; Huitfeldt HS; Langdon WY
Oncogene; 2003 Nov; 22(52):8509-18. PubMed ID: 14627991
[TBL] [Abstract][Full Text] [Related]
2. Direct interaction of Cbl with pTyr 1045 of the EGF receptor (EGFR) is required to sort the EGFR to lysosomes for degradation.
Grøvdal LM; Stang E; Sorkin A; Madshus IH
Exp Cell Res; 2004 Nov; 300(2):388-95. PubMed ID: 15475003
[TBL] [Abstract][Full Text] [Related]
3. Cbl and Itch binding sites in ERBB4 CYT-1 and CYT-2 mediate K48- and K63-polyubiquitination, respectively.
Meijer IM; van Rotterdam W; van Zoelen EJ; van Leeuwen JE
Cell Signal; 2013 Feb; 25(2):470-8. PubMed ID: 23153581
[TBL] [Abstract][Full Text] [Related]
4. [Ubiquitination of EGF receptors with C-terminal domain deletion and point mutations during endocytosis].
Kondratov KA; Melikova MS; Chernorudskiĭ AL; Kornilova ES
Tsitologiia; 2009; 51(7):617-23. PubMed ID: 19764654
[TBL] [Abstract][Full Text] [Related]
5. The Cbl RING finger C-terminal flank controls epidermal growth factor receptor fate downstream of receptor ubiquitination.
Visser GD; Lill NL
Exp Cell Res; 2005 Dec; 311(2):281-93. PubMed ID: 16246327
[TBL] [Abstract][Full Text] [Related]
6. UV-radiation-induced internalization of the epidermal growth factor receptor requires distinct serine and tyrosine residues in the cytoplasmic carboxy-terminal domain.
Oksvold MP; Thien CB; Widerberg J; Chantry A; Huitfeldt HS; Langdon WY
Radiat Res; 2004 Jun; 161(6):685-91. PubMed ID: 15161351
[TBL] [Abstract][Full Text] [Related]
7. RASopathy-associated CBL germline mutations cause aberrant ubiquitylation and trafficking of EGFR.
Brand K; Kentsch H; Glashoff C; Rosenberger G
Hum Mutat; 2014 Nov; 35(11):1372-81. PubMed ID: 25178484
[TBL] [Abstract][Full Text] [Related]
8. Cbl-CIN85-endophilin complex mediates ligand-induced downregulation of EGF receptors.
Soubeyran P; Kowanetz K; Szymkiewicz I; Langdon WY; Dikic I
Nature; 2002 Mar; 416(6877):183-7. PubMed ID: 11894095
[TBL] [Abstract][Full Text] [Related]
9. c-Cbl directs EGF receptors into an endocytic pathway that involves the ubiquitin-interacting motif of Eps15.
de Melker AA; van der Horst G; Borst J
J Cell Sci; 2004 Oct; 117(Pt 21):5001-12. PubMed ID: 15383614
[TBL] [Abstract][Full Text] [Related]
10. Cbl-family ubiquitin ligases and their recruitment of CIN85 are largely dispensable for epidermal growth factor receptor endocytosis.
Ahmad G; Mohapatra BC; Schulte NA; Nadeau SA; Luan H; Zutshi N; Tom E; Ortega-Cava C; Tu C; Sanada M; Ogawa S; Toews ML; Band V; Band H
Int J Biochem Cell Biol; 2014 Dec; 57():123-34. PubMed ID: 25449262
[TBL] [Abstract][Full Text] [Related]
11. Cortactin overexpression inhibits ligand-induced down-regulation of the epidermal growth factor receptor.
Timpson P; Lynch DK; Schramek D; Walker F; Daly RJ
Cancer Res; 2005 Apr; 65(8):3273-80. PubMed ID: 15833860
[TBL] [Abstract][Full Text] [Related]
12. Alix/AIP1 antagonizes epidermal growth factor receptor downregulation by the Cbl-SETA/CIN85 complex.
Schmidt MHH; Hoeller D; Yu J; Furnari FB; Cavenee WK; Dikic I; Bögler O
Mol Cell Biol; 2004 Oct; 24(20):8981-93. PubMed ID: 15456872
[TBL] [Abstract][Full Text] [Related]
13. Ubiquitin ligase activity of c-Cbl guides the epidermal growth factor receptor into clathrin-coated pits by two distinct modes of Eps15 recruitment.
de Melker AA; van der Horst G; Borst J
J Biol Chem; 2004 Dec; 279(53):55465-73. PubMed ID: 15465819
[TBL] [Abstract][Full Text] [Related]
14. Cbl-dependent ubiquitination is required for progression of EGF receptors into clathrin-coated pits.
Stang E; Blystad FD; Kazazic M; Bertelsen V; Brodahl T; Raiborg C; Stenmark H; Madshus IH
Mol Biol Cell; 2004 Aug; 15(8):3591-604. PubMed ID: 15194809
[TBL] [Abstract][Full Text] [Related]
15. EGF receptor binding and transformation by v-cbl is ablated by the introduction of a loss-of-function mutation from the Caenorhabditis elegans sli-1 gene.
Thien CB; Langdon WY
Oncogene; 1997 May; 14(18):2239-49. PubMed ID: 9174060
[TBL] [Abstract][Full Text] [Related]
16. Epidermal growth factor receptor fate is controlled by Hrs tyrosine phosphorylation sites that regulate Hrs degradation.
Stern KA; Visser Smit GD; Place TL; Winistorfer S; Piper RC; Lill NL
Mol Cell Biol; 2007 Feb; 27(3):888-98. PubMed ID: 17101784
[TBL] [Abstract][Full Text] [Related]
17. A mutant EGF-receptor defective in ubiquitylation and endocytosis unveils a role for Grb2 in negative signaling.
Waterman H; Katz M; Rubin C; Shtiegman K; Lavi S; Elson A; Jovin T; Yarden Y
EMBO J; 2002 Feb; 21(3):303-13. PubMed ID: 11823423
[TBL] [Abstract][Full Text] [Related]
18. A tale of two Cbls: interplay of c-Cbl and Cbl-b in epidermal growth factor receptor downregulation.
Pennock S; Wang Z
Mol Cell Biol; 2008 May; 28(9):3020-37. PubMed ID: 18316398
[TBL] [Abstract][Full Text] [Related]
19. Gefitinib-sensitive EGFR lacking residues 746-750 exhibits hypophosphorylation at tyrosine residue 1045, hypoubiquitination, and impaired endocytosis.
Furukawa M; Nagatomo I; Kumagai T; Yamadori T; Takahashi R; Yoshimura M; Yoneda T; Takeda Y; Goya S; Matsuoka H; Kijima T; Yoshida M; Osaki T; Tachibana I; Greene MI; Kawase I
DNA Cell Biol; 2007 Mar; 26(3):178-85. PubMed ID: 17417946
[TBL] [Abstract][Full Text] [Related]
20. Differential regulation of EGF receptor internalization and degradation by multiubiquitination within the kinase domain.
Huang F; Kirkpatrick D; Jiang X; Gygi S; Sorkin A
Mol Cell; 2006 Mar; 21(6):737-48. PubMed ID: 16543144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
